Device Trial Radar · NCT07891247
Complementary Exercise-Based Therapy for Obstructive Sleep Apnea
Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
May 6, 2025
Primary completion
May 7, 2026
Study completion May 8, 2026
Sponsor
- Lead sponsor
- bioROneAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 23, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 20 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This randomized interventional study evaluates a complementary exercise-based therapy in adults with moderate-to-severe obstructive sleep apnea who are receiving continuous positive airway pressure (CPAP) therapy. A total of 24 participants are assigned to either a complementary rehabilitation program in addition to usual care or to usual care alone. The rehabilitation program is performed for 90 days and includes two approximately 45-minute sessions per day, combining physical exercise, breathing exercises, and cervical-postural rehabilitation. The study evaluates changes in the apnea-hypopnea index, nocturnal oxygen saturation, sleep fragmentation, daytime sleepiness, quality of life, psychological symptoms, cardiovascular and respiratory parameters, body mass index, and cervical spine alignment.
Conditions
- Obstructive Sleep Apnea
Interventions
Multimodal Exercise, Respiratory and Cervical-Postural Rehabilitation ProgramBehavioral
A 90-day structured rehabilitation program including physical conditioning, neuromotor and postural exercises, cervical mobility and relaxation exercises, controlled breathing and respiratory-awareness techniques, and relaxation/body-awareness strategies. Participants continue prescribed CPAP and usual clinical care throughout the intervention.
Continuous Positive Airway Pressure (CPAP)Device
Participants continue their prescribed home CPAP therapy and other clinically indicated usual care throughout the study period.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Residual Apnea-Hypopnea Index (AHI) During CPAP TherapyTime frame: Baseline and Day 90
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Clinical Rehabilitation Hospital Iași
Iași, Iaşi, Romania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.